SEC Form 4 · accession 0001127602-16-067135
MERIDIAN BIOSCIENCE INC · VIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Rolih
Officer — EVP, Reg & Quality Systems
Period of report
Nov 11, 2016
Accepted (ET)
Nov 15, 2016 · 2:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000794172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 11, 2016 | M | 15,750 | $16.554 | A | 164,160 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $16.554 | Nov 11, 2016 | M | 15,750 | D | — | Nov 15, 2016 | Common Stock | 15,750 | 0 | D |
Explanation of responses
- F1These options became fully vested in November 2010.